Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma.
Comin-Anduix B, Lee Y, Jalil J, Algazi A, de la Rocha P, Camacho LH, Bozon VA, Bulanhagui CA, Seja E, Villanueva A, Straatsma BR, Gualberto A, Economou JS, Glaspy JA, Gomez-Navarro J, Ribas A
J Transl Med 2008, 6:22
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Commentary    
Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology
Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, Ambs S, Akutsu Y, Chaussabel D, Doki Y, Eremin O, Fridman WH, Hirohashi Y, Imai K, Jacobson J, Jinushi M, Kanamoto A, Kashani-Sabet M, Kato K, Kawakami Y, Kirkwood JM, Kleen TO, Lehmann PV, Liotta L, Lotze MT, Maio M, et al.
Journal of Translational Medicine 2009, 7:45 (17 June 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

2.


Research    
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
von Euw E, Chodon T, Attar N, Jalil J, Koya RC, Comin-Anduix B, Ribas A
Journal of Translational Medicine 2009, 7:35 (20 May 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]


This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.